Carvedilol ER 40 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FY3VJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,552
Award facts
- Contract value 100% obligated
- $3,552.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a ceiling value of $3,552.43. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by April 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor primarily supporting military and veteran healthcare systems. The company's substantial prime IDC with the Defense Logistics Agency functions as a comprehensive global pharmaceutical support vehicle enabling delivery of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. Through its competitive contract awards with the DLA, AmerisourceBergen demonstrates proven capability to fulfill federal medical supply requirements across multiple therapeutic domains, including specialty medications, generic and brand-name drugs, and medical supplies needed by the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FY3VJ?
SPE2DB25FY3VJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FY3VJ worth?
The government has obligated $3,552 on SPE2DB25FY3VJ.
Is contract SPE2DB25FY3VJ an order under another contract?
Yes. SPE2DB25FY3VJ is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY3VJ competed?
The extent of competition for SPE2DB25FY3VJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award